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I N T R O D U C T I O N
Continuous ambulatory peritoneal dialysis (CAPD) is an effective renal replacement therapy. During chronic dialysis, residual renal function, which reflects the residual glomerular filtration rate (GFR), is monitored regularly because it can influence morbidity, mortality and quality of life [1] [2] [3] [4] . Averaging the clearance of creatinine (Cr) and urea over a 24-h period is considered to approximate residual renal function reasonably well [5] , but collecting urine over a 24-h period can pose a substantial burden on patients. This highlights the need for a simple and reliable indicator of residual renal function in patients on CAPD.
Some studies suggest that CysC may be a good marker for predicting GFR [6] [7] [8] . Cystatin C (CysC) is a 13-kDa housekeeping protein expressed at constant levels in all nucleated cells [9] . It is filtered by the glomerulus, reabsorbed by tubular epithelial cells and subsequently catabolized [10] . Researchers have proposed CysC-based equations for estimating residual renal function in patients on peritoneal dialysis [11, 12] . Hoek et al. [11] , in the Netherlands, proposed a simple equation based on serum CysC concentrations and found that it outperformed the Modification of Diet in Renal Disease formula [13] . They suggested using this CysC formula to calculate residual GFR in dialysis patients when 24-h urine samples are unavailable. Yang et al. [12] , in China, developed a hyperbolic model based on serum levels of CysC, which they concluded can reliably estimate residual renal function in patients on CAPD.
The accuracy and reliability of these CysC-based equations are controversial. Carter et al. [14] found that Hoek's CysC formula showed good agreement with residual renal function based on averaging urea and Cr clearance over 24 h and on clearance of 51 Cr-ethylenediaminetetraacetic acid (EDTA). On the other hand, Ahmadi et al. [15] [16] .
Therefore, we aimed to validate published CysC-based equations for estimating residual renal function in a relatively large cohort of 255 patients on CAPD in China.
M A T E R I A L S A N D M E T H O D S

Patients
All patients who received treatment at the Peritoneal Dialysis Center of the Department of Nephrology of West China Hospital, Sichuan University (Chengdu, China) between August 2010 and March 2012 were eligible for recruitment. To be enrolled, patients had to be >18 years of age, had to be on CAPD >1 month at the time of study enrollment and had to have residual urine volume >100 mL. Patients were excluded if they had any of the following: major surgery; bleeding or bleeding tendencies within the previous 2 weeks; advanced cancer; thyroid dysfunction; mental disorders; use of contraceptives within the past 6 months or use of drugs that might affect Cr, including cimetidine and trimethoprim, during the preceding 4 weeks. The study protocol was approved by the local research ethics committee and all patients gave written informed consent.
Methods
Data collection and laboratory measurements. Patient data were collected on age, gender, body weight, height, body mass index (BMI), duration of peritoneal dialysis and preexisting renal disease. Venous blood was obtained after 12-h (overnight) fasting. Samples of 24-h urine and peritoneal dialysis fluid were analyzed for CysC, Cr, urea and protein loss. CysC levels in serum and dialysate were determined using the latex enhanced immunoturbidimetric method. Cr levels were measured using the Jaffe method. Within-and between-assay variation was 3.1 and 2.8% for CysC. Levels of hemoglobin, albumin and calcium in serum were determined using colorimetry and phosphorus was assayed using phosphomolybdic acid. All these biochemical tests were done on the Roche Cobas 8000 automated biochemical analyzer. Intact parathyroid hormone (iPTH) was assessed by electrochemiluminescence immunoassay on the Roche E170 automatic immunoassay analyzer. Levels of prealbumin and high-sensitivity C-reactive protein (hsCRP) were quantified using rate nephelometry on a Beckman Coulter IMMAGE 800.
Residual renal function and peritoneal kinetic assessment. Residual renal function was calculated in mL/ min/1.73 m 2 by averaging Cr and urea clearance and adjusting for body surface area (BSA) [5] . BSA was calculated using the Gehan and George equation [17] Statistical analysis. All analyses were performed using SAS 9.4 (SAS Institute, Cary, NC, USA), with a threshold of significance of 0.05. Data were expressed as mean 6 standard deviation (SD) for continuous variables and total number (percentage) for categorical variables. A group t-test or Wilcoxon rank test was used to compare the group differences for continuous variables. The v 2 test and Fisher's exact test were used to compare results for categorical variables. Correlations were assessed for significance using the Pearson's correlation coefficient in the case of normally distributed data or Spearman's rank correlation coefficient in the case of nonnormally distributed data. Partial correlation analysis was used to explore correlations between two variables; this analysis controlled for other factors that might influence the variables.
A Bland-Altman plot was used to evaluate graphically the agreement between eRRF and mRRF [18] . Bias was expressed as absolute difference and relative difference. The absolute difference was calculated as the difference between estimated and measured residual renal function (eRRF À mRRF), while the relative difference was the corresponding percent difference [(eRRF À mRRF)/mRRF Â 100]. The precision of estimates was assessed by calculating the limits of agreement and associated 95% confidence intervals. Accuracy was expressed as the percent of eRRF within 30% of mRRF (P 30 ) or within 50% of mRRF (P 50 ).
We also compared the performance of the three equations by calculating the area under the curve (AUC) [19] . We calculated sensitivity and specificity using a cutoff value for residual renal function of 2.0 mL/min/1.73 m 2 , since GFR <2.0 mL/ min/1.73 m 2 is considered to indicate significant loss of residual renal function [20] . All patients underwent CAPD involving glucose-based solutions (1.5 or 2.5%). Infused fluid volume varied from 4 to 10 L/ day (two to five exchanges of 2 L/day) and most patients (97.25%) received 6-8 L/day. Ultrafiltration volume was 539.96 6 543.37 mL/day.
R E S U L T S
Patient characteristics and peritoneal dialysis regimes
A total of 90 anuric patients, who had 24-h urine volumes <100 mL, were excluded from the study. Their serum level of CysC was 7.43 6 1.16 mg/L.
Correlation analysis
Correlation analysis revealed no significant association of serum CysC level with age, gender, height, weight, BMI, hemoglobin, iPTH, nPCR or presence of diabetes (Table 2) . Serum CysC level did correlate negatively with 24-h urine volume (r s ¼ À0.4074, P < 0.001), peritoneal CysC clearance (r s ¼ À0.2334, P ¼ 0.0002) and mRRF (r s ¼ À0.5312, P < 0.001). Conversely, serum CysC level positively correlated with the duration of peritoneal dialysis, serum albumin, prealbumin and hsCRP. The association of serum CysC level with hsCRP and prealbumin remained significant after controlling for other variables in partial correlation analysis (Table 3 ; r s ¼ 0.1444, P ¼ 0.0259; r s ¼ 0.1386, P ¼ 0.0325).
In contrast to serum CysC levels, serum Cr levels showed significant associations with age, gender, height, weight and BMI. Serum Cr levels correlated positively with the duration of peritoneal dialysis, iPTH, phosphorus, serum albumin and prealbumin. Cr level correlated negatively with 24-h urine volume, peritoneal CysC clearance (r s ¼ À01295, P ¼ 0.0388) and mRRF (r s ¼ À0.5774, P < 0.001).
Analysis of possible correlations among CysC level, Cr level and parameters of dialysis adequacy showed that both CysC ) showed that in all three cases, correlations between mRRF and eRRF were weaker in the lowmRRF subgroup (Table 4) .
Validation and comparison of equations
Analysis of agreement between mRRF and eRRF is presented in Table 5 and differences between eRRF and mRRF as a function of mRRF are plotted in Figure 1 for The AUC, sensitivity and specificity of the three equations are presented in Table 6 . For Hoek's equation, the AUC was 0.54 (95% CI 0.47, 0.61) (P ¼ 0.320), sensitivity was 1.00 and specificity was 0. We compared the characteristics of our patients with those in studies describing and validating the equations [11, 12, 14, 15] in order to analyze similarities and differences (Table 7) .
D I S C U S S I O N
Residual renal function strongly influences the morbidity, mortality and quality of life of patients on CAPD. Such function is Tc m -DTPA. However, these measurements are invasive, time consuming and expensive. In addition, radioisotope-based measurements are less accurate when GFR <30 mL/min/1.73 m 2 [21] . Therefore, official guidelines recommend averaging urea and Cr clearance in 24-h urine, which was the gold standard applied in the present work. However, for routine clinical practice, 24-h urine collection is cumbersome and, if not done accurately, can lead to misleading results. Here, we tested the possibility that published equations based on serum CysC levels can reliably estimate residual renal function. Our results from a sample of 255 Chinese patients on CAPD suggest that these equations need to be developed and refined before they can be used reliably in the clinic. In our sample, serum CysC level was not associated with age, gender, height, weight, BMI, hemoglobin, iPTH, nPCR or presence of diabetes. Serum CysC level correlated negatively with mRRF (r s ¼ À0.53, P < 0.001), similar to the correlations reported by Hoek (r ¼ À0.55), Yang (r ¼ À0.59) and Ros (r ¼ À0.60) [22] . Serum CysC level also showed a weak association with serum prealbumin level (r s ¼ 0.19, P ¼ 0.0024; partial r s ¼ 0.1386, P ¼ 0.0325), similar to the results of Yang (r ¼ 0.20). These results confirm that CysC is affected by nutrition status [12, 23] . We also found serum CysC levels to be weakly associated with hsCRP (r s ¼ 0.17, P ¼ 0.0060; partial r s ¼ 0.1444, P ¼ 0.0259), consistent with the results of studies by Stevens et al. [24] and Knight et al. [25] . How or why serum CysC levels may be associated with a nutritional marker and hsCRP is unclear. In any event, the observed associations are quite weak and are not likely to affect the clinical relevance of CysC. We found no correlations of peritoneal Kt/V urea with peritoneal cCr or serum CysC, in agreement with the results of Yang et al. [12] and Delaney et al. [26] . There was, however, a weak association between serum CysC and peritoneal CysC clearance (r s ¼ À0.2334, P ¼ 0.0002). This indicates that CysC was cleared via the peritoneal membrane [27, 28] , which may affect the reliability of the CysC equations [28, 29] . The extent of this peritoneal clearance relative to renal clearance is difficult to assess, given that CysC is catabolized in the renal tubules. Peritoneal CysC clearance correlated negatively with mRRF (r s ¼ À0.1583, P ¼ 0.0114): the better the residual renal function, the less peritoneal CysC clearance. These results may depend on the type of dialysis fluid used. All patients in our study received glucose-based solutions (1.5 or 2.5%), and Bruschi et al. [30] reported that peritoneal CysC clearance in children may be higher with icodextrin-based fluid than with glucose solutions. Further studies may be needed to evaluate the relationship between peritoneal CysC clearance and mRRF in adults receiving different types of peritoneal fluid.
In our study, mRRF was overestimated by both Hoek's formula (2. Nevertheless, all three equations gave mean estimates significantly different from mRRF, with similar limits of agreement. These results suggest that none of the three equations is ideal for estimating residual renal function in patients on CAPD [15, 27, 29] .
Several factors may explain differences between our results with Chinese patients and the results reported by Hoek et al. in Dutch patients. Serum CysC levels can depend on ethnicity, based on large-scale studies [24] . This may help explain why the validation study of Carter et al. [14] , involving another European cohort, supported the Hoek equation in contrast to our results. Other explanations may relate to the fact that the patients in Hoek's study had higher plasma albumin concentrations than our patients (37.5 6 5.0 versus 34.2 6 5.2 g/L), as well as higher mRRF (3.3 6 1.5 versus 2.56 6 2.07 mL/min/ 1.73 m 2 ; Table 5 ). Yang's CysC equation performed better in their study than in ours in terms of bias, accuracy, sensitivity and specificity. This may reflect the fact that the patients in Yang's study had been on peritoneal dialysis for a shorter time (5.5 versus 10.4 months) and had higher plasma albumin concentrations (39.2 6 4.3 versus 34.2 6 5.2 g/L). Both parameters have been associated with serum CysC levels. Another possible explanation may be bias: Yang's results came from internal validation, while ours were from external validation.
In our study, Yang's CysC equation underestimated mRRF, while it overestimated mRRF in the study by Ahmadi et al. [15] . This discrepancy may again reflect ethnic differences in patient populations. Indeed, those authors observed a positive correlation between serum CysC levels and RRF, whereas we observed a negative correlation (r s ¼ À0.53). Other potentially relevant differences were that patients in the study by Ahmadi et al. had lower mRRF (0.7 6 1.6 versus 2.56 6 2.07 mL/min/1.73 m 2 ) and plasma albumin concentrations (32.0 6 6.0 versus 34.2 6 5.2 g/L), and they had been much longer on peritoneal dialysis (24 versus 10.4 months). Lastly, the proportion of patients with diabetes was higher in that study.
The major limitation of our study is that the true residual renal function was unknown, so that some of the discrepancy between eRRF and mRRF may reflect the difference between mRRF and the true RRF. When measuring renal function by averaging Cr and urea clearance over 24 h as we did, accurate urine collection is key, especially at low levels of renal function.
C O N C L U S I O N S
Serum CysC level does not correlate significantly with gender, age, BMI or peritoneal Kt/V urea in patients with CAPD, though it does appear to correlate with peritoneal CysC clearance, prealbumin and hsCRP. Published CysC equations are not ideal for estimating residual renal function in CAPD patients. Further development and validation of CysC equations should take into account peritoneal CysC clearance and other relevant factors.
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